Hsa-microRNA-101 suppresses migration and invasion by targeting Rac1 in thyroid cancer cells

Oncology Letters

Volumn 8, Issue 4, 2014, Pages 1815-1821

  Wang, Chenghai ^a   Lu, Sijia ^a   Jiang, Jixin ^b   Jia, Xiaoqin ^a   Dong, Xiaoyun ^a   Bu, Ping ^a  

^a CLINICAL MEDICAL COLLEGE OF YANGZHOU UNIVERSITY   (China)

^b YANGZHOU UNIVERSITY   (China)

Author keywords

Adenocarcinoma; Biopsy; Invasion; Migration; miR 101; Rac1; Thyroid cancer

Indexed keywords

MICRORNA 101; RAC1 PROTEIN;

3' UNTRANSLATED REGION; ADULT; ARTICLE; CELL INVASION; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; LUCIFERASE ASSAY; LYMPH NODE METASTASIS; MALE; RAC1 GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID CANCER CELL LINE; THYROID CARCINOMA; WESTERN BLOTTING;

EID: 84928390434     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.2361     Document Type: Article

References (31)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J cancer 127: 2893-2917, 2010.
2. Qian BY, Hem M, Dong SF, Wang JF and Chen KX: Incidence and mortality of thyroid cancers in Tianjin from 1981 to 2001. Zhonghua Nei Fen Mi Dai Xie Za Zhi 5: 432-434, 2005 (In Chinese).
3. Perri F, Lorenzo GD, Scarpati GD and Buonerba C: Anaplastic thyroid carcinoma: A comprehensive review of current and future therapeutic options. World J Clin Oncol 2: 150-157, 2011.
4. Hunt JP, Buchmann LO, Wang L and Abraham D: An analysis of factors predicting lateral cervical nodal metastases in papillary carcinoma of the thyroid. Arch Otolaryngol Head Neck Surg 137: 1141-1145, 2011.
5. Onoda N, Ishikawa T, Kawajiri H, Takashima T and Hirakawa K: Pattern of initial metastasis in the cervical lymph node from papillary thyroid carcinoma. Surg Today 43: 178-184, 2013.
6. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
7. Ambros V: The evolution of our thinking about microRNAs. Nat Med 14: 1036-1040, 2008.
8. Carthew RW and Sontheimer EJ: Origins and mechanisms of miRNAs and siRNAs. Cell 136: 642-655, 2009.
9. Wang HJ, Ruan HJ, He XJ, Ma YY, Jiang XT, Xia YJ, Ye ZY and Tao HQ: MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion. Eur J Cancer 46: 2295-2303, 2010.
10. Su H, Yang JR, Xu T, Huang J, Xu L, Yuan Y and Zhuang SM: MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res 69: 1135-1142, 2009.
11. Li S, Fu H, Wang Y, Tie Y, Xing R, Zhu J, Sun Z, Wei L and Zheng X: MicroRNA-101 regulates expression of the v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS) oncogene in human hepatocellular carcinoma. Hepatology 49: 1194-1202, 2009.
12. Wang R, Wang HB, Hao CJ, Cui Y, Han XC, Hu Y, Li FF, Xia HF and Ma X: MiR-101 is involved in human breast carcinogenesis by targeting Stathmin1. PLoS One 7: e46173, 2012.
13. Hao Y, Gu X, Zhao Y, Greene S, Sha W, Smoot DT, Califano J, Wu TC and Pang X: Enforced expression of miR-101 inhibits prostate cancer cell growth by modulating the COX-2 pathway in vivo. Cancer Prev Res (Phila) 4: 1073-1083, 2011.
14. Hiroki E, Akahira J, Suzuki F, Nagase S, Ito K, Suzuki T, Sasano H and Yaegashi N: Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas. Cancer Sci 101: 241-249, 2010.
15. Zhang J, Socolovsky M, Gross AW and Lodish HF: Role of Ras signaling in erythroid differentiation of mouse fetal liver cells: functional analysis by a flow cytometry-based novel culture system. Blood 102: 3938-3946, 2003.
16. He L and Hannon GJ: MicroRNAs small RNAs with a big role in gene regulation. Nat Rev Genet 5: 522-531, 2004.
17. Didsbury J, Weber RF, Bokoch GM, Evans T and Snyderman R: rac, a novel ras-related family of proteins that are botulinum toxin substrates. J Biol Chem 264: 16378-16382, 1989.
18. del Pozo MA, Price LS, Alderson NB, Ren XD and Schwartz MA: Adhesion to the extracellular matrix regulates the coupling of the small GTPase Rac to its effector PAK. EMBO J 19: 2008-2014, 2000.
19. Chung CY, Lee S, Briscoe C, Ellsworth C and Firtel RA: Role of Rac in controlling the actin cytoskeleton and chemotaxis in motile cells. Proc Natl Acad Sci USA 97: 5225-5230, 2000.
20. Zhao SY, Sun Y, Lai ZS, Nan QZ, Li K and Zhang ZS: Inhibition of migration and invasion of colorectal cancer cells via deletion of Rac1 with RNA interference. Mol Cell Biochem 322: 179-184, 2009.
21. Chen QY, Xu LQ, Jiao DM, Yao QH, Wang YY, Hu HZ, Wu YQ, Song J, Yan J and Wu LJ: Silencing of Rac1 modifies lung cancer cell migration, invasion and actin cytoskeleton rearrangements and enhances chemosensitivity to antitumor drugs. Int J Mol Med 28: 769-776, 2011.
22. Zhen C, Chen L, Zhao Q, Liang B, Gu YX, Bai ZF, Wang K, Xu X, Han QY, Fang DF, et al: Gankyrin promotes breast cancer cell metastasis by regulating Rac1 activity. Oncogene 32: 3452-3460, 2013.
23. Hernández E, De La Mota-Peynado A, Dharmawardhane S and Vlaar CP: Novel inhibitors of Rac1 in metastatic breast cancer. P R Health Sci J 29: 348-356, 2010.
24. Kamai T, Shirataki H, Nakanishi K, Furuya N, Kambara T, Abe H, Oyama T and Yoshida K: Increased Rac1 activity and Pak1 overexpression are associated with lymphovascular invasion and lymph node metastasis of upper urinary tract cancer. BMC Cancer 10: 164, 2010.
25. Yap LF, Jenei V, Robinson CM, Moutasim K, Benn TM, Threadgold SP, Lopes V, Wei W, Thomas GJ and Paterson IC: Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation. Oncogene 28: 2524-2534, 2009.
26. Wang P, Chen L, Zhang J, Chen H, Fan J, Wang K, Luo J, Chen Z, Meng Z and Liu L: Methylation-mediated silencing of the miR-124 genes facilitates pancreatic cancer progression and metastasis by targeting Rac1. Oncogene 23, 514-524, 2014.
27. Imam JS, Plyler JR, Bansal H, Prajapati S, Bansal S, Rebeles J, Chen HI, Chang YF, Panneerdoss S, Zoghi B, et al: Genomic loss of tumor suppressor miRNA-204 promotes cancer cell migration and invasion by activating AKT/mTOR/Rac1 signaling and actin reorganization. PLoS One 7: e52397, 2012.
28. Zhou Y, Su J, Shi L, Liao Q and Su Q: DADS downregulates the Rac1-ROCK1/PAK1-LIMK1-ADF/cofilin signaling pathway, inhibiting cell migration and invasion. Oncol Rep 29: 605-612, 2013.
29. Gupta GP and Massagué J: Cancer metastasis: building a framework. Cell 127: 679-695, 2006.
30. Klein CA: Cancer. The metastasis cascade. Science 321: 1785-1787, 2008.
31. Sreekumar R, Sayan BS, Mirnezami AH and Sayan AE: MicroRNA control of invasion and metastasis pathways. Front Genet 2: 58, 2011.